Denali Capital Acquisition Corp. (DECA) earnings
Quarterly and annual DECA reports and results, each read against the price at its own news timestamp. Back to the DECA overview →
15 measured DECA earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Semnur Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Semnur Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Semnur Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Denali Capital Acquisiti For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q Denali Capital Acquisiti For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 10-K Denali Capital Acquisiti For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form NT 10-K Denali Capital Acquisiti For: Dec 31 | SEC filing · Form NT | +0.00% | +0.08% | |
| Form 10-Q Denali Capital Acquisiti For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q Denali Capital Acquisiti For: Sep 30 | SEC filing · Form NT | — | — | |
| Form 10-Q Denali Capital Acquisiti For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q Denali Capital Acquisiti For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 10-Q Denali Capital Acquisiti For: Mar 31 | SEC filing · Form 10-Q | -3.92% | -4.74% | |
| Form NT 10-Q Denali Capital Acquisiti For: Mar 31 | SEC filing · Form NT | -0.84% | +0.70% | |
| Form 10-K Denali Capital Acquisiti For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.31% | |
| Form 10-Q Denali Capital Acquisiti For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.09% |
Keep exploring
More DECA: analyst actions → · SEC filings → · DECA overview →